BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33130749)

  • 1. [Mediastinal Growing Teratoma Syndrome during Chemotherapy, Presenting as a Huge and Inoperable Tumor].
    Kato H; Fukushima T; Kobayashi T; Sekiguchi N; Kanda S; Koizumi T
    Gan To Kagaku Ryoho; 2020 Oct; 47(10):1497-1500. PubMed ID: 33130749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of angiosarcoma in a mediastinal non-seminomatous germ cell tumor that exhibited growing teratoma syndrome during chemotherapy.
    Matsuoka S; Koyama T; Takeda T; Yamada K; Hyogotani A; Hamanaka K; Sekiguchi N; Koizumi T
    Thorac Cancer; 2019 Jan; 10(1):111-115. PubMed ID: 30407736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paclitaxel+BEP (T-BEP) regimen as induction chemotherapy in poor prognosis patients with nonseminomatous germ cell tumors: a phase II study.
    Tryakin A; Fedyanin M; Kanagavel D; Fainstein I; Sergeev J; Polockij B; Matveev V; Zakharova T; Garin A; Tjulandin S
    Urology; 2011 Sep; 78(3):620-5. PubMed ID: 21764427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A Case of Primary Mediastinal Seminoma Showing Local Increase in Residual Tumor after Chemotherapy].
    Hattori Y; Mitsumori K; Hayata N; Nakamura K; Takahashi T; Ohnishi H; Kawai K
    Hinyokika Kiyo; 2020 May; 66(5):153-155. PubMed ID: 32483951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growing teratoma syndrome in primary mediastinal germ cell tumor: our experience.
    Sachdeva AK; Penumadu P; Kohli P; Dubashi B; Munuswamy H
    Asian Cardiovasc Thorac Ann; 2019 Feb; 27(2):98-104. PubMed ID: 30646758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP.
    Culine S; Kramar A; Théodore C; Geoffrois L; Chevreau C; Biron P; Nguyen BB; Héron JF; Kerbrat P; Caty A; Delva R; Fargeot P; Fizazi K; Bouzy J; Droz JP;
    J Clin Oncol; 2008 Jan; 26(3):421-7. PubMed ID: 18202419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The "growing teratoma syndrome" in primary mediastinal nonseminomatous germ cell tumors: criteria based on current practice.
    Kesler KA; Patel JB; Kruter LE; Birdas TJ; Rieger KM; Okereke IC; Einhorn LH
    J Thorac Cardiovasc Surg; 2012 Aug; 144(2):438-43. PubMed ID: 22713299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
    Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
    Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience with bleomycin, etoposide, cisplatin (BEP) and alternating cisplatin, cyclophosphamide, doxorubicin (CISCA(II))/vinblastine, bleomycin (VB(IV)) regimens of chemotherapy in poor-risk nonseminomatous germ cell tumors.
    Culine S; Théodore C; Bekradda M; Farhat F; Terrier-Lacombe MJ; Droz JP
    Am J Clin Oncol; 1997 Apr; 20(2):184-8. PubMed ID: 9124197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The primary mediastinal growing teratoma syndrome.
    Iyoda A; Hiroshima K; Yusa T; Toyozaki T; Fujisawa T; Ohwada H
    Anticancer Res; 2000; 20(5C):3723-6. PubMed ID: 11268445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome of patients with clinical stage I high-risk nonseminomatous germ-cell tumors 15 years after one adjuvant cycle of bleomycin, etoposide, and cisplatin chemotherapy.
    Vidal AD; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
    Ann Oncol; 2015 Feb; 26(2):374-7. PubMed ID: 25392157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
    Fizazi K; Pagliaro L; Laplanche A; Fléchon A; Mardiak J; Geoffrois L; Kerbrat P; Chevreau C; Delva R; Rolland F; Theodore C; Roubaud G; Gravis G; Eymard JC; Malhaire JP; Linassier C; Habibian M; Martin AL; Journeau F; Reckova M; Logothetis C; Culine S
    Lancet Oncol; 2014 Dec; 15(13):1442-1450. PubMed ID: 25456363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mediastinal somatic-type germ cell tumor with hepatic metastasis successfully treated by multiple modalities.
    Kobayashi N; Koizumi T; Eguchi T; Hyogotani A; Saito G; Hamanaka K; Shiina T; Kurai M; Kondo R; Yoshida K; Amano J
    Anticancer Res; 2010 Dec; 30(12):5117-20. PubMed ID: 21187499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of germ-cell tumor of the mediastinum].
    Horimasu Y; Kitaguchi S; Ohe M; Doi M; Maeda H; Doi M; Kuwabara M
    Nihon Kokyuki Gakkai Zasshi; 2011 Jan; 49(1):44-8. PubMed ID: 21384681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes following surgery for primary mediastinal nonseminomatous germ cell tumors in the cisplatin era.
    Kesler KA; Stram AR; Timsina LR; Turrentine MW; Brown JW; Einhorn LH
    J Thorac Cardiovasc Surg; 2021 Jun; 161(6):1947-1959.e1. PubMed ID: 32446546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Teratoma following cisplatin-based combination chemotherapy for nonseminomatous germ cell tumors: a clinicopathological correlation.
    Loehrer PJ; Hui S; Clark S; Seal M; Einhorn LH; Williams SD; Ulbright T; Mandelbaum I; Rowland R; Donohue JP
    J Urol; 1986 Jun; 135(6):1183-9. PubMed ID: 2423708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for metastatic testicular teratoma: long-term follow-up.
    Dearnaley DP; Horwich A; A'Hern R; Nicholls J; Jay G; Hendry WF; Peckham MJ
    Eur J Cancer; 1991; 27(6):684-91. PubMed ID: 1712606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Case of Primary Mediastinal Non-Seminomatous Germ Cell Tumor with Pathological Complete Response after Induction Chemotherapy and Residual Tumor Resection Accompanied by Late-Onset Bilateral Pneumothorax].
    Fujii T; Kitahara S; Matsunaga T; Kobayashi S; Sahara N; Matsui T; Otsuka A; Ishida Y; Ishii H; Kurosaki Y; Itoh S; Hasegawa H; Ohno N
    Gan To Kagaku Ryoho; 2020 Jan; 47(1):87-90. PubMed ID: 32381869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group.
    Albers P; Siener R; Krege S; Schmelz HU; Dieckmann KP; Heidenreich A; Kwasny P; Pechoel M; Lehmann J; Kliesch S; Köhrmann KU; Fimmers R; Weissbach L; Loy V; Wittekind C; Hartmann M;
    J Clin Oncol; 2008 Jun; 26(18):2966-72. PubMed ID: 18458040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Induction chemotherapy and radical resection for primary nonseminomatous mediastinal germ cell tumor (NSGCT); report of a case].
    Yatsuyanagi E; Kusajima K; Suzuki M; Hirano T; Sakurada T; Kikuchi Y; Sugawara Y
    Kyobu Geka; 2004 Feb; 57(2):168-71. PubMed ID: 14978917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.